Walgreens Boots Alliance: Deep-Dive Analysis

Summary

  • As WBA continues to flat-line due to margin pressures, it is becoming an increasingly attractive value play.
  • Neighbourhood health destinations provide an effective experience-based solution to transforming retail for WBA moving forward.
  • Fully-owned and developed lines such as No7 provide opportunities for significant margin improvements and differentiation.

Investment Thesis

Walgreens Boots Alliance (WBA) continues to flat-line as pressures on margins and low sales growth continue to negatively impact share price. However, at current valuations, WBA is becoming increasingly attractive as a value play with a broadly defensible moat.

Company Background

Founded in 1901, Walgreens Boots Alliance remains the world retail leader in pharmaceutical products, complemented by a range of cosmetics (including own brands), personal care, and other consumer goods and services from opticians to photo services. The group employs 287,000 employees, has a market cap of $38.58bn on revenues of $138.58bn (FY 2019), and profits of $3.98bn (FY 2019).

Seeking Alpha

Read the full article exclusively on Seeking Alpha.

Read more
Seeking Alpha